Interference No. 105,188 Short v. Punnonnen According to one embodiment, plasmid DNA is introduced into a simian COS cell line . . . by known methods of transfection . . . and allowed to replicate and express cDNA inserts. The transfectants expressing B7-1 antigen are 5 depleted with an anti-B7-1 monoclonal antibody . . . and anti-murine IgG and IgM coated immunomagnetic beads. Transfectants expressing human B7-2 antigen can be positively selected by reacting the transfectants with the fusion proteins CTLA4Ig and CD28Ig, followed by panning with 10 anti-human Ig antibody coated plates. Although human CTLA4Ig and CD28Ig fusion protiens were used in the examples described herein, given the cross-species reactivity between B7-1 and, for example murine B7-1, it can be expected that other fusion proteins reactive with another cross-reactive 15 species could be used. After panning, episomal DNA is recovered from the panned cells and transformed into a competent bacterial host . . . . Plasmid DNA is subsequently reintroduced into COS cells and the cycle of expression and panning repeated at least two times. After 20 the final cycle, plasmid DNA is prepared from individual colonies, transfected into COS cells and analyzed for expression of novel B lymphocyte antigens by indirect immunofluorescence with, for example, CTLA4Ig and CD28Ig. 25 Example 4 (Exh. 2040, B. Cloning Procedure, p. 72, ll. 6-32) and Example 6 (Exh. 2040, B. Cloning Procedure, p. 80, ll. 8-34) explain how the recursive screening steps of the procedures described in the Freeman PCT select polynucleotide sequences which encode novel human or murine B7-2 variants having markedly 30 enhanced or inhibited immune responses to a vaccine vector. Focusing on the detailed teachings of the Freeman PCT, we find that one method described in this primary reference for obtaining an immunomodulatory polynucleotide that encodes a B7-2 antigen which has an altered modulatory effect on an immune 35 response induced by a genetic vaccine vector as compared to the -12-Page: Previous 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 NextLast modified: November 3, 2007